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Abstract
Hard tissues are natural nanocomposites comprising collagen nanofibers that 
are interlocked with hydroxyapatite (HAp) nanocrystallites. This mechanical inter-
locking at the nanoscale provides the unique properties of hard tissues (bone and 
teeth). Upon fracture, cements are usually used for treatment of simple fractures 
or as an adhesive for the treatment of complicated fractures that require the use of 
metallic implants. Most of the commercially available bone cements are polymer-
based, and lack the required bioactivity for a successful cementation. Besides 
calcium phosphate cements, gypsum is one of the early recognized and used 
biomaterials as a basi for a self-setting cementation. It is based on the controlled 
hydration of plaster of Paris at room temperature and its subsequent conversion to 
a self-setting solid gypsum product. In our work, we have taken this process further 
towards the development of a set of nanocomposites that have enhanced bioactivity 
and mechanical properties. This chapter will outline the formation, characteriza-
tion, and properties of gypsum-based nanocomposites for bone cement applica-
tions. These modified cements can be formulated at room temperature and have 
been shown to possess a high degree of bioactivity, and are considered potential 
candidates for bone fracture and defect treatment.
Keywords: gypsum, bone cement, nanocomposite, biomimetic, apatite-forming 
ability
1. Introduction
Hard tissues, such as bone and teeth, are natural composites consisting of two 
types of material. The first material is an organic extracellular matrix that contains 
collagen, accounts for approximately 30–35% of the dry weight of bone, and is 
responsible for providing flexibility and resilience to the bone. The second mate-
rial consists primarily of calcium and phosphorous salts, especially hydroxyapatite 
[Ca10(PO4)6(OH)2; HAp], accounts for approximately 65–70% of the dry weight of 
bone, and contributes to the hardness and rigidity of the bone [1]. Hard tissues, in 
general, are responsible for providing support for the whole body, for the attachment 
to ligaments and tendons, and protect vital organs. Based on the composition of hard 
tissues, they are also considered as a reservoir for the minerals in addition to iron that 
maintains the process of hemostasis.
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Bone can be classified macroscopically as cortical tissue and cancellous 
(trabecular) tissue [1]. Both types are morphologically lamellar bone. Cortical 
tissue relies on osteons for cell communication. Because trabecular width is small, 
the canaliculi can communicate directly with blood vessels in the medullary 
canal. The basic differences between cortical tissue and cancellous tissue relate 
to porosity and apparent density. The porosity of cortical tissue typically ranges 
from 5–30%, and that of cancellous tissue ranges from 30–90%. The apparent 
density of cortical tissue is approximately 1.8 g/cm3, and that of cancellous tissue 
typically ranges from 0.1 to 1.0 g/cm3. The distinction between cortical tissue and 
cancellous tissue is arbitrary. However, in biomechanical terms, the two tissues 
are often considered one material with a specific range of porosity and density.. 
The organization of cortical and cancellous tissue in bone allows adaptation to 
function. Cortical tissue always surrounds cancellous tissue, but the relative 
quantity of each type of tissue varies with the bone’s functional requirements. 
In long bones, the diaphysis’s cortical tissue is arranged as a hollow cylinder to 
best resist bending. The metaphyseal region of the long bones flares to increase 
the bone volume and surface area in a manner that minimizes the stress of joint 
contact. The cancellous tissue in this region provides an intricate network that 
distributes weight-bearing forces and joint reaction forces into the bulk of the 
bone tissue [2–4]. Figure 1 shows a schematic diagram of a typical human bone, 
showing its detailed composition as well as the various types of bone.
If fractured or damaged, hard tissues are either left to self-heal, depending on the 
extent of the fracture or replaced partially or totally by an implant. Figure 2 shows 
the mechanism of self-healing of fractured bone. However, surgical intervening is 
mostly required to ensure proper fixation of the fractured bone and avoid future 
health consequences. In this regard, natural or synthetic materials, also known 
as biomaterials, are often used to partially or totally fix the fractured bone. The 
term “biomaterials” is used to indicate materials that constitute parts of medical 
implants, extracorporeal devices, and disposables utilized in medicine, surgery, 
dentistry, veterinary medicine, and in every aspect of patient health care [5, 6].
Biomaterials can be generally divided into three main categories that are regulated 
by tissue reaction. In basic context, inert materials (more narrowly, almost inert) 
preclude no or minimal tissue reaction. Active materials enhance bonding to surround 
tissue by promoting, for example, new bone formation. In the underlying tissue, 
degradable or resorbable materials are introduced or can even dissolve completely 
over a period. Commonly, metals are inert, ceramics may be inert, active or resorb-
able, and polymers may be resorbable or inert. The main property required of a 
biomaterial is that it does not elicit an adverse reaction when placed into service. In 
addition to biomaterials used for partial or total fixation of the fractured bone, an 
additional class of materials known as “bone cements” is also used for stand-alone 
Figure 1. 
Detailed structure of a typical human bone.
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fixation of the fractures bone or as an auxiliary material with other biomaterials to 
help in the fixation process. More details about bone cements will be discussed in the 
following sections.
2. Bone cements
By definition, bone cements are biomaterials that are obtained by mixing a pow-
der phase with a liquid phase, forming a paste that can solidify into a final set product 
upon implantation within the body [7]. Bone cements are highly characterized by the 
ability to be injected in the body, extending their application to minimally invasive 
surgical applications [7]. The first known bone cement is poly(methyl methacrylate) 
(PMMA), which was used in 1940s as a bone filler to close fractures and defects in the 
skull [8]. PMMA was also used to fix total hip arthroplasty replacement components, 
similar to a total hip replacement [9]. This process takes place through the in-situ 
polymerization of the PMMA; hence a set product is formed.
Biocompatible polymeric bone cements are further classified as bioinert, 
bioactive, or biodegradable depending on their composition. However, none of 
them possesses a similar chemical composition to that of natural hard tissues. 
Accordingly, non-polymeric bone cements were investigated. These include calcium 
phosphate cements, as well as gypsum-based cements [10]. These cements are based 
on formulations that are composed of the mineral powder and an aqueous liquid. 
Their blending results in the hydration of the powder and the instant chemical 
transformation to the final set product [10].
2.1 Gypsum bone cements
Gypsum is one of the first used biomaterials. It is a common non-metallic 
mineral consisting of hydrated calcium sulfate (CaS04·2H20). It crystallizes in the 
monoclinic system in white or colorless crystals; Gypsum is formed through the 
hydration of its hemihydrate precursor (Plaster of Paris; POP) according to Eq. (1):
 CaSO · H O H O CaS0 ·2H+ →
4 2 2 4 2
½ 1½ 0  (1)
This reaction can take place at room temperature. A two-phase suspension of 
hemihydrate particles in a saturated aqueous solution is formed as the hemihydrate 
dissolves. Crystals nucleate in the suspension as the solution becomes super-
saturated with dihydrate and form a precipitate. Until the solution is no longer 
Figure 2. 
Self-healing process involved in a fractured human bone.
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saturated, nucleation and crystal formation proceed, leading to the further dissolu-
tion of the hemihydrate. Alternative dissolution and precipitation keep, with the 
growth of existing crystals or nucleation of new crystals [11].
The transformation of POP to gypsum is often followed by simple characteriza-
tion techniques, such as x-ray diffraction (XRD), infrared spectroscopy (IR), and 
scanning electron microscopy (SEM). Figure 3 shows a comparison between the 
XRD patterns (3a), IR spectra (3b), and SEM micrographs of POP and gypsum 
phases. POP is characterized by its XRD peaks at 2Ө values of 14.79, 25.48, 29.34, 
29.77, 31.84, 33.03, 38.46, 39.77, 41.34, 42.31, 45.36, 47.64, 48.66, and 49.32o; as 
shown in Figure 3a. Gypsum, on the other hand, is characterized by its XRD peaks 
at 2Ө values of 11.64, 20.76, 23.43, 25.48, 28.19, 29.17, 31.13, 32.16, 33.35, 34.61, 
36.02, 36.611, 37.38, 40.69, 42.20, 43.40, 44.27, 45.57, 46.49, 47.06, and 48.51o; as 
shown in Figure 3a. These peaks were in accordance with their standard XRD cards 
01–0999, and 33–0311 for gypsum and POP phases, respectively.
Figure 3b shows the IR spectra of POP and gypsum solid powders. Both POP 
and gypsum have water of crystallization, ½ H2O in POP, and 2H2O in gypsum. This 
was shown in the IR spectra as relatively broad bands with medium-strong intensi-
ties. Both appeared as a doublet at 3549.7 and 3607 cm−1 [12]. In the IR spectrum of 
gypsum, more broadness of this assembly was observed, extending its absorption 
to have a broad shoulder at 3416 cm−1 [12]. These differences are attributed to the 
difference in the proportion of water of crystallization in the two phases. Sulfate 
ions are shown in these phases’ patterns at four places; a sharp strong intensity 
doublet at 604 and 656 cm−1, a relatively broad but very strong band with a peak at 
1143.9 cm−1, and a medium intensity sharp band at 1630.9 cm−1 [12]. All four bands 
appeared with almost the same intensity in the two IR spectra of POP and gypsum.
The microstructure of POP and gypsum powders is shown in Figure 3c,d. POP 
phase is known to exist in the form of irregular shaped crystals with a polydisperse 
particle size distribution, as shown in Figure 3c. Upon reaction with water and 
formation of gypsum, the dissolution-precipitation mechanism by which reaction 
proceeds results in the formation of smaller crystallites with a more uniform size 
distribution, as shown in Figure 3d.
Figure 3. 
Physico-chemical characterization of gypsum and POP: (a) X-ray diffraction analysis, (b): Fourier-
transformed infrared spectroscopy, Scanning electron micrographs of (c) POP and (d) gypsum powders.
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There are two varieties of the gypsum hemihydrate form, α- and β-, which differ 
in crystal size, surface area, and lattice imperfections. While these materials are 
chemically similar, their physical properties vary considerably. The dental stone 
from which diagnostic casts is the α-hemihydrate type. When compared to the 
β-hemihydrate, it is very difficult and relatively insoluble. The β-hemihydrate is 
distinguished by an aggregate of interstitial capillary pores of abnormal crystals, 
while the α-hemihydrate comprises cleavage fragments and rod and prism-shaped 
crystals [13]. The α-form needs much less water than the β-form (0.3 versus 0.6 g/g 
of hemihydrate, respectively) due to their various particle characteristics. As a 
result, the α-form results in a super thick, heavier and less soluble dihydrate than 
the β-form [11]. The formed gypsum exhibits a layered structure with the water 
molecules alternating with calcium sulfate layers explaining this mineral’s easy 
cleavage [14], as shown in Figure 4. The hemihydrate has the water molecules 
arranged in channels between chains of calcium sulfate. It explains the ease with 
which this compound can lose most of its coordinated water without disrupting the 
structure.
Gypsum as one of the oldest known construction materials today is manu-
factured in a huge amounts for renders, plasters, indoor finishing, retardants for 
cement, ceramics, and medical supplements or implants [15–20].  The wide 
applications of gypsum plaster are primarily based on its unique properties, e.g., 
setting time, suitable workability, and volume stability. However, some disadvan-
tages appear when neat gypsum plaster is used, where a relatively high amount of 
water is required for mixing. The setting time may accordingly be too long, and as a 
result, it adversely affects the set product’s mechanical properties. These properties 
are merely developed by introducing other ingredients to form what is known as 
gypsum composites as an attempt to improve the plaster properties.
Gypsum is a highly biocompatible material that is one of the simplest synthetic 
bone graft materials with the longest clinical history, spanning more than 100 years 
[21]. It is classified as a bioresorbable material. It has been used effectively for the 
treatment of periodontal disorders, endodontic lesions, alveolar bone loss and 
augmentation of the maxillary sinus [21]. It has also been used to promote healing 
and stop failure of the grafting material as a binder. In addition, it is tissue compli-
ant and does not interfere with the process of healing [22]. At rates as high as 1 mm 
per week, Ricci et al. [23] observed a rapid rate of dissolution of both in vitro and in 
vivo gypsum from the outer surface inwards. Despite this dissolution, they reported 
Figure 4. 
Crystal structure of (a) gypsum, and (b) POP phases [14].
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that while bone was not observed to come into direct contact with gypsum, gypsum 
stimulated new bone formation. The formed bone took the shape of concentric 
rings in surrounding tissue, and histologically, these deposits stain like bone mineral 
and often showed attachment of osteoid and new bone [23].
2.2 Biomedical applications of gypsum bone cements
Gypsum and its precursor; POP, have been used as bone void fillers for more 
than a century [24]. Kelly et al. in 2001 used Osteosets (surgical grade calcium 
sulfate, Wright Medical Technology, Arlington TN) to fill bone defects caused by 
benign bone tumors, trauma, cyst, etc. [25]. They concluded that surgical grade 
calcium sulfate is reliable, convenient, safe, and readily available bone graft sub-
stitute that yields consistent results [25]. Osteosets, Borrelli et al. [26] successfully 
treated non-union osseous defects caused by trauma with a combination of autog-
enous iliac bone and Osteoset using the same surgical-grade gypsum. In 2005, Chen 
et al. concluded that, as an artificial bone expander with a fair fusion rate, surgeons 
may use calcium sulfate combined with locally harvested morselized bone [27].
Lazary et al. showed that MC3T3-E1 osteoblastic mouse cells placed on a gypsum 
disc expressed genes that are relevant in the formation of new bones in a way that 
is different and better than poly(methyl methacrylate) (PMMA), which is a typical 
bone void filler [28]. They also concluded that a more effective bone repair envi-
ronment was created by gypsum. Because of its unique crystal structure and high 
calcium content, it is also chosen to have the potential for osteoinductivity [27, 28]. In 
addition to the above-mentioned characteristics, Rohmiller et al. suggested gypsum 
as a cement for lumbar pedicle screw fixation [29]. They found it more promising 
than PMMA, in particular because, unlike the exothermic hardening of PMMA 
[29], no heat forms during its framework. In a parallel study, it was found that cells 
plated on gypsum disc express genes important in new bone formation with different 
expression ratios compared to PMMA, generally used as a bone void filler, suggesting 
that gypsum provides a more efficient environment for bone repair. These findings 
indicate that gypsum possess a potential Osteoinductivity, as a result of its special 
crystal structure and high calcium content [30].
Properties and applications of gypsum-based bone cements were also enhanced 
through the inclusion of various types of additives; natural or synthetic and inor-
ganic or organic. One of these additives’ main objectives is to improve the bioactive 
and mechanical properties of gypsum as a bone cement so that its biomedical 
applications are further extended. One of the first reports about the use of additives 
to gypsum was shown by Sanad et al. in 1982, where a combination of calcium oxide 
(CaO) and gum Arabic was found to enhance the mechanical properties of gypsum 
[31]. This was related to lime (CaO) precipitation in the hydration and setting 
processes of POP, while the gum Arabic acted as a gluing matrix [31].
One of the effective approaches to modulating the mechanical properties of 
gypsum [32–35] has been considered to be the blending of gypsum with polymers. 
The presence of such functional groups, such as hydroxyl and carboxyl groups, on 
these polymers is often preferred. These were found to connect with the gypsum 
products set together with the calcium sites. In general, polymers that do not 
have these groups are passive during the gypsum setting reaction. However, the 
mechanical interlocking of these polymers with the gypsum crystals collected 
improves the overall mechanical performance of the composites made. For bio-
medical applications, polymers used with gypsum should be biocompatible to avoid 
rejection by the human immune system. Different polymers could be used in this 
regard, ranging from bioactive to bioinert, depending on the application type and 
site. El-Maghraby et al. evaluated gypsum composites with poly(vinyl alcohol) and 
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its copolymers with vinyl acetate and itaconic acid [36]. They concluded that the 
presence of carboxylic acid-groups along the polymeric ingredients enhanced the 
mineralization ability of the produced composites. In another study, a novel inject-
able, photo-cross-linkable PCL/calcium sulfate system has been developed to over-
come calcium sulfate brittleness and fast resorption rate enhancing its performance 
in bone regeneration techniques [37]. Moreover, the addition of viscous polymers, 
such as Carboxymethylcellulose (CMC), and hyaluronan, improved the handling 
characteristics and mechanical properties of the CS [38, 39]. Gelatin was also used 
as a natural additive to a mixture of gypsum and POP, which result in the formation 
of a porous scaffold upon setting [40]. This novel composite system showed high 
potential in tissue engineering applications [40]. Mineralization of a gypsum-PLLA 
composite bone cement indicated that the material may be osteoconductive. Both 
gypsum and PLLA are classified as bioresorbable biomaterials. Therefore, their 
composite bone cement can be designed in such a way that its overall degradation 
can be controlled [41, 42].
2.3 Resorption of gypsum bone cement
Gypsum is classified as a resorbable biomaterial. This characteristic does not 
interfere with its wide application as a bone cement, where the resorption of 
gypsum cement after implantation could be controlled to match the fixation of the 
fractured bone and the subsequent bone formation. The resorption of gypsum has 
been studied by various authors. Randolph et al. patented the ideas of having it in 
the form of pellets that will release certain ingredients upon dissolution [43–45]. 
Besides, Hanker et al. patented the gypsum resorption concept for the repair of 
damaged bone [46]. Doadrio et al. developed a gypsum-based cement and used it to 
deliver an antibiotic; cephalexin [47]. The inclusion of this drug was shown not to 
affect the structural composition or the physicochemical properties of gypsum [47].
Despite the benefit of gypsum bioresorption, which makes it an appealing 
candidate for particular applications, its relatively low mechanical properties have 
limited its scope of use as a bone replacement implant or even as bone cement. To 
boost its mechanical properties, various materials were mixed with gypsum; what 
is referred to as biphasic composites [48]. POP has often been mixed with various 
ceramic and polymeric ingredients to form gypsum composites there from.
On the other hand, the expedited sorption rate of gypsum can be reduced 
significantly through the use of various additives, particle/bead size, and sintering 
techniques of the ready-made gypsum made biomaterials. It was shown that the 
degradation rate of sintered CS specimens can be adjusted through the introduc-
tion of pores. Through various techniques, the introduction of spherical pores 
with amounts ranging from 6.7 to 68% into sintered CS specimens was reflected 
on a corresponding variable degradation rate in Hank’s solution in the range of 
1.9–7.7%/day [49]. Upon using different-sized calcium sulfate beads, their ability 
to elute multiple antibiotics in vitro was observed, as a possible method to improve 
the therapeutic delivery in patients [50].
2.4 Intrinsic bioactivity of gypsum bone cements
Preliminary evaluation of biomaterials, implants, and cements is intended to 
be in a closer contact with hard tissues, occurs through the study of the bone-like 
apatite formation and growth ability of the potential biomaterials. This process is 
also termed “biomimetic”, where bone-like apatite formation and growth resembles 
the natural mineralization of collagen in nature, which takes place during the con-
tinued bone formation process with time. This process was discussed in details in a 
Novel Nanomaterials
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previous work by Hafiz Uddin et al. [51] and was first recognized and established by 
Kokubo et al. in 1981 and reported in 1990 [52].
The hypothesis behind this approach is to mimic the biomineralization process 
where Ca2+ and PO4
3− ions deposit in the form of apatite nanocrystallites onto 
certain nucleation sites along the collagen nanofibers. These nucleation sites are the 
functional groups along with the various amino acids within the collagen fibrils, 
such as -OH, -COOH, and -NH2 groups. Accordingly, biomaterials that possess any 
of these groups upon the immersion of a simulated body fluid (SBF), will undergo 
a similar mechanism resulting in the deposition of bone-like apatite spherolites, 
which were shown to contain apatite nanocrystallites. Protein-free SBF media 
contain ions with concentrations similar to those in the human blood plasma, and 
are supersaturated with respect to stoichiometric HAp (Ca/P 1.67). Table 1 shows a 
detailed composition of a typical SBF solution.
The mechanism of biomimetic deposition of bone-like apatite takes place at a 
physiologic pH and temperature through the instant gravitation and binding of 
the Ca2+ ions from the solution onto the surface functional groups, followed by 
the attachment of the PO4
3− ions, hence nuclei of bone-like HAp are formed. Upon 
continued immersion in SBF, these nuclei further grow and adopt a typical bone-
like apatite morphology. Figure 5 shows a schematic representation of the apatite 
formation’s biomimetic process onto OH-carrying biomaterial surfaces, such as 
silicate-containing implants.. Similarly, biomaterial surfaces that provide these 
functional groups were widely explored for the biomimetic formation of nanostruc-
tured bone-like apatite.
Gypsum, as a final set product, was also investigated in our laboratories for its 
affinity towards the biomimetic deposition of bone-like HAp [36, 53]. In a typical 
experiment, gypsum samples were immersed in a freshly prepared SBF medium 
and maintained at a physiologic temperature of 37.4°C for up to 2 weeks. Aliquots 
were collected at various time intervals to study the variation of the most relevant 
ions; Ca2+, PO4
3−, and SO4
2−, in the medium as a function of time. Dry samples at 
the end of the 15-days experiment were collected and studied by scanning electron 
microscopy for the variation of its surface morphology. Figure 6 shows typical 
SEM micrographs of a SBF-treated gypsum sample (b), compared to a pristine 
gypsum sample (a). Upon further treatment of the SBF-treated gypsum sample in 
a more concentrated SBF solution (1.5X), further growth of the deposited apatite 
nanostructured spherolites were shown with a more detailed bone-like morphology 
as shown in Figure 6c. Elemental analysis of the nanostructured spherolites indi-
cated the presence of Ca and P peaks that confirmed the identity of the deposited 
apatite [36, 53].
In a typical SBF experiment, both Ca2+ and PO4
3− ions are leached out from 
solution as a result of initially being supersaturated with respect to these ions. This 
process results in the precipitation of the corresponding nanostructured bone-like 
apatite spherolites. Chemical analysis of these ions with time usually confirms 








SBF 142.0 5.0 2.5 1.5 4.2 148.0 1.0 0.5
Blood plasma 142.0 5.0 2.5 1.5 27.0 103.0 1.0 0.5
Table 1. 
A detailed composition of a typical SBF solution, compared with a blood plasma [52].
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showed the decrease of the concentration of the PO4
3− ions with time, with an 
unexpected increase in the concentration of the Ca2+ ions, as shown in Figure 7 
[53]. To explain this behavior, the concentration of SO4
2− ions were also analyzed 
and was also proven to show a continued increase with time. The combined increase 
in the concentrations of Ca2+ and SO4
2− ions with time was attributed to gypsum’s 
bioresorbable nature. It is believed that the process of biomimetic mineralization 
of gypsum takes place through a combined mechanism of dissolution (via resorp-
tion) of gypsum crystal surfaces and the subsequent release of Ca2+ and SO4
2− ions 
into solution. This is followed by an abrupt increase in the supersaturation of the 
SBF medium with respect to Ca2+ and PO4
3− ions and their eventual precipitation 
in the form of the nanostructured bone-like apatite spherolites. Gypsum bone 
cement with biomimetically grown nano-textured apatite was successfully used as 
a drug delivery vehicle in addition to its cementation effect. This is attributed to the 
add-value of the nanotextured apatite spherolites that can be used as drug carriers, 
where the sorption of gypsum cement results in the slow release of the drugs. An 
example was shown in the sustained release cephalexin and gentamicin from both 
pure calcium sulfate and nanocomposite cements into SBF, which was demon-
strated in the work of Hesaraki et al. [54].
2.5 Nano-textured gypsum bone cements with enhanced bioactivity
In addition to the intrinsic bioactivity of pristine gypsum bone cements and its 
ability to form bone-like nano-textured apatite on its surfaces, these bioactivity 
indicators were further enhanced through the inclusion of bioactive fillers. These 
include calcium phosphates, which are known for their structural similarity to bone 
apatite, and calcium silicates, which were the first candidates to show an enhanced 
affinity to grow bone-like nanotextured apatite spherolites in SBF media [55–62]. In 
addition, POP-based biomaterials have also exhibited promise as grafts in a pre-
clinical repair model of intrabony periodontal defects, as well as in clinical reports 
for sinus augmentation and treatments of femoral shaft non-unions [60–62].
Figure 5. 
A schematic representation of the mechanism of biomimetic deposition of bone-like apatite spherolites on a 
typical silicate-based biomaterial; before (a), and after (b) immersion in a simulated body fluid.
Figure 6. 
Scanning electron micrographs of (a) set gypsum surface and nanotextured, bone-like apatite formation onto 
the surfaces of a set gypsum cement sample after immersion in (b) SBF and (c) 1.5 SBF media at 37°C.
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2.6 Calcium phosphate-doped gypsum bone cements
POP was applied to enhance the setting reactions of a biodegradable calcium 
phosphate cement that was composed of β-tricalcium phosphate (β-Ca3(PO4)2; 
β-TCP) and monocalcium phosphate monohydrate (Ca(H2PO4)2.H2O; MCPM) 
[56] due to its relatively faster setting process. These composites of cement have 
been shown to be osteo-conductive [56]. The setting time, workability, and poros-
ity of a cement composed of an aqueous slurry of β –TCP [57] were also modulated 
using POP. When combined with β-TCP, Nilsson et al. [58] realized the essential 
function of gypsum, helping to create pores in the implanted material, thereby 
ensuring the growth of new bone tissue. The use of β-TCP in a CS matrix produced 
significantly more vital new bone fill and preserved bone dimensions than β-TCP 
alone [59]. Composite bone cement was also made of gypsum and granules of 
β-TCP, and dicalcium phosphate dihydrate, and were shown to have a greater bone 
filling ability than did pure gypsum cement [60]. Moreover, the physical proper-
ties of the bone regenerated with the CS/CP composite were similar to or greater 
than native bone [60].
Combinations of ready-made HAp particles with gypsum were also evalu-
ated. Sato et al. indicated the promising characteristics of gypsum after mixing 
it with HAp particles, based on the relatively fast absorption of gypsum without 
interfering with bone healing [48]. Cabanas et al. concluded that for a paste 
of calcium sulfate-calcium phosphate cements to be injected percutaneously 
using a syringe or implanted operatively, it was essential to control parameters 
such as working time, setting time, or thermodynamic behavior [61]. It was also 
shown by Guo et al. that a calcium phosphate-doped gypsum bone cement has a 
controlled setting time within the range of 5–20 min., and the material can easily 
be molded before setting [62]. A novel HAp-gypsum-POP cement system was 
successfully used as a reservoir for the delivery of growth factor-beta 1 (TGF-1) 
and vascular endothelial growth factor (VEGF) [63].
Two novel dual-setting apatite-gypsum bone cements were studied, in which the 
setting reaction of POP and its transformation to gypsum was combined with the 
setting reaction of apatitic calcium phosphate precursors [64, 65]. These precur-
sors normally react with water at room temperature through an acid–base reaction 
Figure 7. 
Variation of the ionic concentrations of Ca2+, PO4
3–, and SO4
2– ions in SBF media with time as a result of 
immersion of gypsum samples for up to 15 days at 37°C.
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leading to the formation of calcium phosphate bone cements with various degrees 
of stoichiometry, as shown in Eqs. (2) and (3):
 ( ) ( ) ( ) ( )2Ca PO O 2CaHPO .2H O Ca PO OH+ → SHAp4 4 4 2 10 42 6 2  (2)
( ) ( )( ) ( ) ( )3Ca PO O 6CaHPO .2H O 2Ca HPO PO OH+ → −CD HAp4 4 4 2 9 4 42 5  (3)
As observed in both cases, the findings showed a remarkable delay in the growth 
kinetics of gypsum, with different extensions depending on the starting Ca/P molar 
ratios of the apatite and its proportion in the composites. The synthetic version of 
Ca-def apatite’s bioresorbability also revealed its retardation effect on the formation 
of gypsum. An overall near-physiological pH regimen was obtained by mixing POP 
in their solutions with each of the Ca-def apatites [64]. However, variations in the 
pH of the studied solutions showed the effect of POP on decreasing the alkalinity of 
the media containing SHAp precursors [65].
Fabrication of osteoconductive scaffold with osteoinductive capability 
and appropriate resorption rate was also achieved through the introduction of 
Strontium in the crystal structure of gypsum as well as the combined effect of HAp. 
Together, Sr-gypsum/HAp was shown to promote bone formation by recruiting and 
stimulating osteogenic differentiation of BMSCs [66].
2.7 Calcium silicate-doped gypsum bone cements
Silicate-based materials have been proven to possess an excellent affinity 
towards the biomimetic deposition of nano-textured bone-like apatite spherolites 
in SBF media. Accordingly, they were considered bioactive, and their inclusion in 
the formation of composite biomaterials is highly believed to lead to enhancement 
of the bioactivity of the biomaterials produced thereof. Accordingly, silicates were 
considered potential candidates to be added to gypsum bone cements to further 
enhance their bioactivity. Silicate-based materials; either crystalline or amorphous, 
could be used in this regard as they share the mechanism of biomimetic deposition 
of apatite when exposed to SBF media. In the work of Greish et al. [53], highly 
crystalline wollastonite fibers were added to gypsum bone cements in order to 
study their effect on the mechanical properties and bioactivity of the produced 
composite cement systems. Due to the silicate composition of the wollastonite fibers 
and the gypsum matrix’s intrinsic bioactivity, both phases were shown to develop 
nano-structured apatite coatings onto their surfaces; Figure 8a. Furthermore, 
alkali-treated wollastonite fibers were shown to have an extensive formation of 
these apatitic coatings on its surfaces, as shown in Figure 8b. These novel cements 
provide a dual mechanism of biomimetic deposition of the bone-like spherolites, 
hence show an enhanced bioactivity as compared with pure gypsum cements [53]. 
Tricalcium silicate was also added to gypsum in the work of Huan et al. [67] to 
improve its handling and physical properties, in addition to improved mechanical 
properties. Furthermore, the composite made thereafter was also shown to have 
enhanced bioactivity and favorable resorption characteristics as compared with 
pure gypsum cement [67]. A ternary organic–inorganic composite bone cements 
of tricalcium silicate/sodium alginate/POP (C3S/SA/POP) were successfully shown 
to exhibit good proliferation, excellent attachment, enhanced alkaline phosphatase 
activity, increased calcium deposition, and osteogenic-related gene expressions 
with growing calcium sulfate component [68].
In the course of 3D printing, POP was also supplemented with silicate materials. In 
order to boost the scaffold efficiency, a combined cement was integrated functionally 
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into mesoporous calcium silicate (MCS) via a 3D printing technique. Compared to 
printed MCS scaffolds, the characteristics showed that 20 percent CSH integration over 
4 weeks of hydration increased their compressive strength by 2 times. Moreover, MCS 
component in the composite scaffolds exhibited sustained release behavior of dexa-
methasone drugs to assist bone regeneration [69]. Similarly, scaffolds made of POP 
and mesoporous bioactive glass (MBG) scaffolds successfully fabricated using a 3D 
printing technique, which had a regular and uniform square macroporous structure, 
high porosity and excellent apatite mineralization ability. Thus 3D printed POP/MBG 
scaffolds would be promising candidates for promoting bone regeneration [70].
3. Conclusions
Bone cements are widely used for the treatment of bone defects and fractures. 
Gypsum-based bone cements are characterized by their ease of preparation and 
affordability. Gypsum has been classified as a bioresorbable material. Moreover, 
our ongoing research has clearly shown a string evidence of its bioactivity where 
gypsum is mineralized in SBF media in a manner similar to that was initially pro-
posed for the biomimetic growth of bone-like apatite on the surfaces of bioactive 
materials. Moreover, the inclusion of other biocompatible fillers further enhance its 
bioactivity. The biomimetically-grown bone-like apatite adopts the morphology of 
nanostructured spherolites which are made of apatite nanocrystallites. The overall 
assembly of nanostructured gypsum-based bone cements, therefore, represents a 
potential modality for the treatment of fractured bone with an enhanced bioactivity. 
Moreover, an added value of the improvement in the mechanical properties of these 
composite cements is highly believed to extend the applications of these cements to 
be used as bone implants for non-load bearing applications.
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Figure 8. 
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fibers, after immersion in SBF media for 15 days at 37°C.
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